Also known as: CJC-1295 with DAC
CJC-1295 DAC is a synthetic peptide that functions as an extended-life analog of Growth Hormone-Releasing Hormone (GHRH). It belongs to the category of growth hormone peptides, designed to stimulate the release of growth hormone from the pituitary gland. This peptide is characterized by its ability to enhance endogenous growth hormone levels over an extended period, making it a subject of interest in various research contexts.
CJC-1295 DAC is distinguished by its Drug Affinity Complex (DAC), which prolongs its half-life in the bloodstream, allowing for less frequent dosing compared to other GHRH analogs. This unique feature makes it a valuable tool for researchers studying growth hormone dynamics and its physiological effects.
CJC-1295 DAC operates by binding to specific receptors in the pituitary gland, thereby stimulating the release of growth hormone. The peptide mimics the natural GHRH, promoting the pulsatile secretion of growth hormone, which is crucial for various metabolic processes.
The DAC component enhances the stability and bioavailability of CJC-1295, allowing it to remain active in the system for longer durations. This leads to sustained elevation of growth hormone levels, which can influence various physiological functions.
CJC-1295 DAC serves as a significant tool in the study of growth hormone dynamics, offering extended release and sustained effects. Its applications in muscle growth, fat loss, and recovery highlight its relevance in both research and potential therapeutic contexts.
Last updated: Feb 25, 2026